Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — neurotransmitter wellness

Dried urine testing is rapidly becoming the preferred method for neurotransmitter and hormone assessment — but collection timing is everything. In this clinical overview, Dr. Kate Placzek of ZRT Laboratory explains why a single morning urine sample cannot substitute for a 4-time-point collection, how neurotransmitters like epinephrine and norepinephrine follow distinct diurnal rhythms, and why interchanging the first and second morning voids can produce grossly inaccurate results.

Neurotransmitter testing is one of the most powerful functional assessment tools available — but it requires a nuanced approach to interpretation. In this clinical overview, Dr. Kate Placzek of ZRT Laboratory outlines the key fundamentals every practitioner needs before reading a neurotransmitter report: from understanding patterns over numbers and treatment sequencing, to the clinical significance of low serotonin on SSRIs, GABA’s peripheral mechanisms, and when to run a diurnal catecholamine assessment.

What do heavy metals, neurotransmitters and hormone imbalances have in common? In this detailed case study, Dr. Kate Placzek examines Loretta — a 62-year-old postmenopausal woman with breast cancer — and shows how comprehensive testing can reveal the complex biochemical picture behind a cancer diagnosis. A compelling read for anyone interested in the role of hormones and toxic exposure in breast health.